Halozyme Therapeutics
HALO
#2363
Rank
A$11.22 B
Marketcap
A$94.77
Share price
2.52%
Change (1 day)
-2.75%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): A$0.72 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are A$1.39 Billion. a decrease over its 2024 earnings that were of A$0.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 A$0.65 B-16.2%
2024 A$0.78 B59.94%
2023 A$0.49 B39.94%
2022 A$0.35 B0.16%
2021 A$0.35 B92.2%
2020 A$0.18 B-278.96%
2019 -A$0.11 Billion-9.45%
2018 -A$0.12 Billion-229.51%
2017 A$87.04 M-160.48%
2016 -A$0.15 Billion216.03%
2015 -A$45.54 Million-52.86%
2014 -A$96.61 Million-18.09%
2013 -A$0.12 Billion55.88%
2012 -A$75.67 Million169.94%
2011 -A$28.03 Million-63.44%
2010 -A$76.66 Million-7.19%
2009 -A$82.6 Million15.91%
2008 -A$71.26 Million83.89%
2007 -A$38.76 Million78.1%
2006 -A$21.76 Million16%
2005 -A$18.76 Million45.24%
2004 -A$12.92 Million682.42%
2003 -A$1.66 Million1659.12%
2002 -A$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$47.40 B 7,086.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.39 B 2,083.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$36.35 B 5,411.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.87 B 1,549.11%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-A$0.72 Billion-208.17%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$43.49 M-93.41%๐Ÿ‡บ๐Ÿ‡ธ USA